Search Results 1901-1910 of 20080 for Receptor

  1. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    ... receptors or mechanisms. * History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years ...

  2. Study to Evaluate the Effectiveness and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy - Mayo Clinic

    ... receptor blockers (ARBs). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  3. Publications - Zach Z. Thompson, M.D. - Mayo Clinic

    Differential Expression of Prostaglandin E2 Receptors in Porcine Kidney Transplants. Transplant Proc. 2019 Jul - Aug; 51 (6):2124-2131. View PubMed; Wang Y ...

  4. Study Of RYZ101 In Combination With SoC In Subjects With SSTR+ ES-SCLC - Mayo Clinic

    ... receptor expressing (SSTR+) ES-SCLC. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  5. Projects - Mayo Clinic Research

    ... receptor (TSHr) — an essential component of the disease mechanism — may benefit patients with thyroid eye disease. Researchers are also collaborating with ...

  6. Publications - Jeremy M. Clain, M.D. - Mayo Clinic

    ... receptors demonstrated using fluorescence spectroscopy. J Biol Chem. 2005 Jan 14; 280 (2):1044-50 Epub 2004 Nov 01. View PubMed. PST-20217029. Home ...

  7. PTSD in Treatment for Major Depression with Ketamine in Intensive Care Unit - Mayo Clinic

    Current treatment includes any medication known to affect the N‐methyl‐D‐aspartate receptor system (e.g., lamotrigine, acamprosate, memantine, riluzole, or ...

  8. Publications - Sumera R. Ahmad, M.B.B.S. - Mayo Clinic

    Impact of Glucagon-Like Peptide-1 Receptor Agonist Exposure on Gastrointestinal Outcomes Among ICU Patients: A Multicenter Matched Cohort Study. Crit Care ...

  9. Find cancer clinical trials - Mayo Clinic

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  10. Metformin for the Prevention of Episodic Migraine (MPEM) - Mayo Clinic

    Migraine pain is associated with the activation and sensitization of specific receptors involved in pain-promoting pathways. Metformin, which is a widely ...